Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continued Access to DRV/Rtv in HIV-1 Infected Children and Adolescents (Rollover Patients From C212, C228, C230)

NCT01138605 is registered in ClinicalTrials.gov with Janssen Sciences Ireland UC as lead sponsor.

NCT NCT01138605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01138605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continued Access to DRV/Rtv in HIV-1 Infected Children and Adolescents (Rollover Patients From C212, C228, C230)
Lead sponsor
Janssen Sciences Ireland UC
Phase
Phase 2
Overall status
Completed
Start date
October 13, 2010
Completion date
November 23, 2017
Enrollment
46 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infections